The promotion of β-cell regeneration by FTZ was associated with the upregulation of key transcription factors (Pdx1, MafA, and Ngn3), suggesting FTZ as a potential therapeutic drug for T1DM [324]. This evidence concerns the gene MAFA and type 1 diabetes mellitus.